G Bozler

406 total citations
25 papers, 345 citations indexed

About

G Bozler is a scholar working on Molecular Biology, Pediatrics, Perinatology and Child Health and Spectroscopy. According to data from OpenAlex, G Bozler has authored 25 papers receiving a total of 345 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Pediatrics, Perinatology and Child Health and 5 papers in Spectroscopy. Recurrent topics in G Bozler's work include Epilepsy research and treatment (5 papers), Analytical Chemistry and Chromatography (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). G Bozler is often cited by papers focused on Epilepsy research and treatment (5 papers), Analytical Chemistry and Chromatography (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). G Bozler collaborates with scholars based in Germany, United States and Sweden. G Bozler's co-authors include G. Heinzel, J. M. van Rossum, Jochen Schmid, Ulrich Busch, Michael P. Kummer, R Hammer, H. Masset, A Dresse, H Weisenberger and F W Koss and has published in prestigious journals such as Analytical Biochemistry, Biometrics and Archives of Biochemistry and Biophysics.

In The Last Decade

G Bozler

25 papers receiving 307 citations

Peers

G Bozler

PHARM

ONCOL

PHARM

Berry J. Kline United States

J. Beckmann Germany

J. Moppert Switzerland

G. Lambelin Canada

G. O. Breault United States

P. Farina Italy

Barbara B. Kitchell United States

Sandra K. Kirkman United Kingdom

Chiyuki Yamato Japan

A Viani Italy

Berry J. Kline United States

G Bozler

90 ×0.9

PHARM

116 ×1.3

67 ×0.9

ONCOL

86 ×1.5

PHARM

29 ×0.7

Citations per year, relative to G Bozler G Bozler (= 1×) peers Berry J. Kline

Countries citing papers authored by G Bozler

Since Specialization

Citations

This map shows the geographic impact of G Bozler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Bozler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Bozler more than expected).

Fields of papers citing papers by G Bozler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Bozler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Bozler. The network helps show where G Bozler may publish in the future.

Co-authorship network of co-authors of G Bozler

This figure shows the co-authorship network connecting the top 25 collaborators of G Bozler. A scholar is included among the top collaborators of G Bozler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Bozler. G Bozler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tanswell, P., et al.. (1990). Absolute bioavailability of pirenzepine in intensive care patients. European Journal of Clinical Pharmacology. 38(3). 265–268. 6 indexed citations

Tanswell, P., et al.. (1989). Steady-state intravenous pharmacokinetics of pirenzepine in patients with differing degrees of renal dysfunction. European Journal of Clinical Pharmacology. 36(1). 75–78. 13 indexed citations

Tanswell, P., et al.. (1989). Steady-state intravenous pharmacokinetics of pirenzepine in patients with hepatic insufficiency and combined renaland hepatic insufficiency. European Journal of Clinical Pharmacology. 36(1). 71–73. 5 indexed citations

Hayakawa, Akira, et al.. (1987). Pharmacokinetics of pirenzepine in patients with gastric or duodenal ulcers.. PubMed. 37(8). 980–2. 1 indexed citations

Bozler, G, et al.. (1983). Pharmacokinetics during Drug Development: Data Analysis and Evaluation Techniques.. Biometrics. 39(2). 537–537. 78 indexed citations

Klein, G., A Wirtzfeld, G Bozler, Ola Rönn, & Christina Graffner. (1982). Compartment model of prenalterol. Acta Medica Scandinavica. 211(S659). 99–107. 2 indexed citations

Dresse, A, et al.. (1982). Pharmacokinetics of oral dipyridamole (Persantine�) and its effect on platelet adenosine uptake in man. European Journal of Clinical Pharmacology. 23(3). 229–234. 59 indexed citations

Busch, Ulrich, M. Molzahn, G Bozler, & F W Koss. (1981). Pharmacokinetics of oxazepam following multiple administration in volunteers and patients with chronic renal disease.. PubMed. 31(9). 1507–11. 7 indexed citations

Ohsugi, Masahiro, et al.. (1980). Metabolism of l-β-lysine by a Pseudomonas: Purification and properties of 3-keto-6-acetamidohexanoate cleavage enzyme. Archives of Biochemistry and Biophysics. 203(1). 437–452. 4 indexed citations

10.

Bozler, G, et al.. (1979). Metabolism of l-β-lysine in a Pseudomonas: Conversion of 6-N-acetyl-l-β-lysine to 3-keto-6-acetamidohexanoate and of 4-aminobutyrate to succinic semialdehyde by different transaminases. Archives of Biochemistry and Biophysics. 197(1). 226–235. 8 indexed citations

11.

Schmid, Jochen, K Beschke, Willy Roth, G Bozler, & F W Koss. (1979). Rapid, sensitive determination of dipyridamole in human plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 163(2). 239–243. 17 indexed citations

12.

Jauch, R, G Bozler, R Hammer, et al.. (1978). [Ambroxol, studies of biotransformation in man and determination in biological samples (author's transl)].. PubMed. 28(5a). 904–11. 13 indexed citations

13.

Heinzel, G., et al.. (1977). [Model building in pharmacokinetics/Part IV: Derivation of microconstants in linear compartment models (author's transl)].. PubMed. 27(4a). 912–28. 1 indexed citations

14.

Heinzel, G., et al.. (1977). [Model building in pharmacokinetics/Part III: Simplified rules for the deduction of analytical solutions for linear compartment models (author's transl)].. PubMed. 27(4a). 904–11. 18 indexed citations

15.

Heinzel, G., et al.. (1977). [Model building in pharmacokinetics/Part II: Generalized theoretical presentation of complete integration of linear compartment models of optional structure (author's transl)].. PubMed. 27(4a). 900–4. 5 indexed citations

16.

Hammer, R, et al.. (1977). Model building in pharmacokinetics/Part V: Simulation of blood level curves following repetitive dosing and their experimental verification (author's transl).. PubMed. 27(4a). 928–31. 1 indexed citations

17.

Rapp, Peter R., et al.. (1973). Positionsermittlung der freien Propionsäuregruppe zweier nucleotidhaltiger Corrinoidmonocarbonsäuren. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 354(2). 970–973. 3 indexed citations

18.

Bozler, G, et al.. (1972). Mikrobiologischer Abbau von 5-Pregnen-3ß,20a-diol, 5-Pregnen-3ß,20ß-diol und Progesteron. Helmholtz-Zentrum für Polar-und Meeresforschung (Alfred-Wegener-Institut). 1 indexed citations

19.

Bozler, G, et al.. (1972). [Microbiologic degradation of 5-pregnene-3 ,20 -diol, 5-pregnene-3 -diol and progesterone].. PubMed. 353(9). 1440–6. 2 indexed citations

20.

Bozler, G, et al.. (1972). Mikrobiologischer Abbau von 5-Pregnen-3β,20α-diol, 5-Pregnen-3β,20β-diol und Progesteron. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 353(2). 1440–1446. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact